{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:24:10Z","timestamp":1787916250348,"version":"build-2784847793"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171852"],"award-info":[{"award-number":["82171852"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0329"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0329"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Center for Child Health and Disorders of China","award":["NCRCCHD-2020-GP-10"],"award-info":[{"award-number":["NCRCCHD-2020-GP-10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angelman syndrome (AS) is a neurodevelopmental disorder caused by abnormal expression of the maternal ubiquitin protein ligase E3A gene (<jats:italic>UBE3A<\/jats:italic>). As one of the most challenging symptoms and important focuses of new treatment, sleep disturbance is reported to occur in 70\u201380% of patients with AS and has a serious impact on the lives of patients and their families. Although clinical studies and animal model studies have provided some clues, recent research into sleep disorders in the context of AS is still very limited. It is generally accepted that there is an interaction between neurodevelopment and sleep; however, there is no recognized mechanism for sleep disorders in AS patients. Accordingly, there are no aetiologically specific clinical treatments for AS-related sleep disorders. The most common approaches involve ameliorating symptoms through methods such as behavioural therapy and symptomatic pharmacotherapy. In recent years, preclinical and clinical studies on the targeted treatment of AS have emerged. Although precision therapy for restoring the UBE3A level and the function of its signalling pathways is inevitably hindered by many remaining obstacles, this approach has the potential to address AS-related sleep disturbance.<\/jats:p>","DOI":"10.1186\/s13023-024-03154-5","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T11:02:03Z","timestamp":1712314923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sleep disturbance in Angelman syndrome patients"],"prefix":"10.1186","volume":"19","author":[{"given":"Song","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-206X","authenticated-orcid":false,"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"issue":"8","key":"3154_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1469-8749.2008.03035.x","volume":"50","author":"H Hart","year":"2008","unstructured":"Hart H. \u201cPuppet\u201d children. A report on three cases (1965). Dev Med Child Neurol. 2008;50(8):564.","journal-title":"Dev Med Child Neurol."},{"issue":"6","key":"3154_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tins.2011.04.001","volume":"34","author":"AM Mabb","year":"2011","unstructured":"Mabb AM, Judson MC, Zylka MJ, et al. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 2011;34(6):293\u2013303.","journal-title":"Trends Neurosci"},{"issue":"10","key":"3154_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","volume":"12","author":"K Buiting","year":"2016","unstructured":"Buiting K, Williams C, Horsthemke B. Angelman syndrome \u2014 insights into a rare neurogenetic disorder. Nat Rev Neurol. 2016;12(10):584\u201393.","journal-title":"Nat Rev Neurol"},{"key":"3154_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.smrv.2017.01.002","volume":"37","author":"K Spruyt","year":"2018","unstructured":"Spruyt K, Braam W, Curfs LMG. Sleep in Angelman syndrome: A review of evidence. Sleep Med Rev. 2018;37:69\u201384.","journal-title":"Sleep Med Rev"},{"issue":"8","key":"3154_CR5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/ajmg.a.61642","volume":"182","author":"JA Pereira","year":"2020","unstructured":"Pereira JA, Ravichandran CT, Mullett J, et al. Characterization of sleep habits and medication outcomes for sleep disturbance in children and adults with Angelman syndrome. Am J Med Genet A. 2020;182(8):1913\u201322.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"3154_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.sleep.2007.07.001","volume":"9","author":"K Pelc","year":"2008","unstructured":"Pelc K, Cheron G, Boyd SG, et al. Are there distinctive sleep problems in Angelman syndrome? Sleep Med. 2008;9(4):434\u201341.","journal-title":"Sleep Med"},{"issue":"3","key":"3154_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s13311-021-01082-x","volume":"18","author":"NA Copping","year":"2021","unstructured":"Copping NA, McTighe SM, Fink KD, et al. Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome. Neurotherapeutics. 2021;18(3):1535\u201347.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"3154_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2788.2011.01499.x","volume":"56","author":"SE Goldman","year":"2012","unstructured":"Goldman SE, Bichell TJ, Surdyka K, et al. Sleep in children and adolescents with Angelman syndrome: association with parent sleep and stress. J Intellect Disabil Res. 2012;56(6):600\u20138.","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"3154_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ajmg.a.36864","volume":"167A","author":"AM Larson","year":"2015","unstructured":"Larson AM, Shinnick JE, Shaaya EA, et al. Angelman syndrome in adulthood. Am J Med Genet A. 2015;167A(2):331\u201344.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"3154_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1352\/0895-8017(2005)110[243:SIIWAS]2.0.CO;2","volume":"110","author":"NC Walz","year":"2005","unstructured":"Walz NC, Beebe D, K B. Sleep in individuals with Angelman syndrome: parent perceptions of patterns and problems. Am J Ment Retard. 2005;110(4):243\u201352.","journal-title":"Am J Ment Retard."},{"issue":"4","key":"3154_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1352\/0895-8017(2004)109<275:SPIIWS>2.0.CO;2","volume":"109","author":"R Didden","year":"2004","unstructured":"Didden R, Korzilius H, Smits MG, et al. Sleep problems in individuals with Angelman syndrome. Am J Ment Retard. 2004;109(4):275\u201384.","journal-title":"Am J Ment Retard"},{"issue":"514","key":"3154_CR12","doi-asserted-by":"publisher","first-page":"eaax2014","DOI":"10.1126\/scitranslmed.aax2014","volume":"11","author":"L Xing","year":"2019","unstructured":"Xing L, Shi G, Mostovoy Y, et al. Mutant neuropeptide S receptor reduces sleep duration with preserved memory consolidation. Sci Transl Med. 2019;11(514):eaax2014.","journal-title":"Sci Transl Med."},{"issue":"13","key":"3154_CR13","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1073\/pnas.1801693115","volume":"115","author":"A Hirano","year":"2018","unstructured":"Hirano A, Hsu PK, Zhang L, et al. DEC2 modulates orexin expression and regulates sleep. Proc Natl Acad Sci U S A. 2018;115(13):3434\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3154_CR14","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-020-0858-6","volume":"26","author":"M Keute","year":"2020","unstructured":"Keute M, Miller MT, Krishnan ML, et al. Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment. Mol Psychiatry. 2020;26(7):3625\u201333.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"3154_CR15","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/j.1460-9568.2009.06716.x","volume":"29","author":"R Winsky-Sommerer","year":"2009","unstructured":"Winsky-Sommerer R. Role of GABAA receptors in the physiology and pharmacology of sleep. Eur J Neurosci. 2009;29(9):1779\u201394.","journal-title":"Eur J Neurosci"},{"issue":"8","key":"3154_CR16","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/genes13081447","volume":"13","author":"X Du","year":"2022","unstructured":"Du X, Wang J, Li S, et al. An Analysis of Phenotype and Genotype in a Large Cohort of Chinese Children with Angelman Syndrome. Genes. 2022;13(8):1447.","journal-title":"Genes"},{"issue":"9","key":"3154_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biopsych.2019.01.008","volume":"85","author":"J Frohlich","year":"2019","unstructured":"Frohlich J, Miller MT, Bird LM, et al. Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes. Biol Psychiat. 2019;85(9):752\u20139.","journal-title":"Biol Psychiat"},{"key":"3154_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13229-018-0214-8","volume":"9","author":"H den Bakker","year":"2018","unstructured":"den Bakker H, Sidorov MS, Fan Z, et al. Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG study. Mol Autism. 2018;9:32.","journal-title":"Mol Autism"},{"issue":"5","key":"3154_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/BF00441976","volume":"147","author":"SG Boyd","year":"1988","unstructured":"Boyd SG, Harden A, Patton MA. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr. 1988;147(5):508\u201313.","journal-title":"Eur J Pediatr."},{"issue":"3","key":"3154_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.yebeh.2011.11.027","volume":"23","author":"M Vendrame","year":"2012","unstructured":"Vendrame M, Loddenkemper T, Zarowski M, et al. Analysis of EEG patterns and genotypes in patients with Angelman syndrome. Epilepsy Behav. 2012;23(3):261\u20135.","journal-title":"Epilepsy Behav"},{"key":"3154_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s11689-017-9195-8","volume":"9","author":"MS Sidorov","year":"2017","unstructured":"Sidorov MS, Deck GM, Dolatshahi M, et al. Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis. J Neurodev Disord. 2017;9:17.","journal-title":"J Neurodev Disord"},{"issue":"4","key":"3154_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/01.WNP.0000167930.90824.0F","volume":"22","author":"CM Korff","year":"2005","unstructured":"Korff CM, Kelley KR, Nordli DR. Notched delta, phenotype, and Angelman syndrome. J Clin Neurophysiol. 2005;22(4):238\u201343.","journal-title":"J Clin Neurophysiol"},{"issue":"11","key":"3154_CR23","first-page":"2685","volume":"116","author":"S Miano","year":"2005","unstructured":"Miano S, Bruni O, Elia M, et al. Sleep breathing and periodic leg movement pattern in Angelman Syndrome: a polysomnographic study. Clin Neurophysiol. 2005;116(11):2685\u201392.","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"3154_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.clinph.2003.11.004","volume":"115","author":"S Miano","year":"2004","unstructured":"Miano S, Bruni O, Leuzzi V, et al. Sleep polygraphy in Angelman syndrome. Clin Neurophysiol. 2004;115(4):938\u201345.","journal-title":"Clin Neurophysiol"},{"key":"3154_CR25","doi-asserted-by":"publisher","first-page":"837523","DOI":"10.3389\/fnbeh.2022.837523","volume":"16","author":"SQ Shi","year":"2022","unstructured":"Shi SQ, Mahoney CE, Houdek P, et al. Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a. Front Behav Neurosci. 2022;16:837523.","journal-title":"Front Behav Neurosci"},{"issue":"5","key":"3154_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cub.2014.12.047","volume":"25","author":"SQ Shi","year":"2015","unstructured":"Shi SQ, Bichell TJ, Ihrie RA, et al. Ube3a imprinting impairs circadian robustness in Angelman syndrome models. Curr Biol. 2015;25(5):537\u201345.","journal-title":"Curr Biol"},{"issue":"7539","key":"3154_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature13975","volume":"518","author":"L Meng","year":"2015","unstructured":"Meng L, Ward AJ, Chun S, et al. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature. 2015;518(7539):409\u201312.","journal-title":"Nature"},{"issue":"11","key":"3154_CR28","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1111\/febs.15258","volume":"287","author":"C Maranga","year":"2020","unstructured":"Maranga C, Fernandes TG, Bekman E, et al. Angelman syndrome: a journey through the brain. FEBS J. 2020;287(11):2154\u201375.","journal-title":"FEBS J"},{"issue":"10","key":"3154_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","volume":"21","author":"Y-H Jiang","year":"1998","unstructured":"Jiang Y-H, Armstrong D, Albrecht U, et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 1998;21(10):799\u2013811.","journal-title":"Neuron"},{"issue":"8","key":"3154_CR30","doi-asserted-by":"publisher","first-page":"e12278","DOI":"10.1371\/journal.pone.0012278","volume":"5","author":"Y-H Jiang","year":"2010","unstructured":"Jiang Y-H, Pan YZ, Zhu L, et al. Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model with a Large Maternal Deletion from Ube3a to Gabrb3. PLoS ONE. 2010;5(8):e12278.","journal-title":"PLoS ONE"},{"key":"3154_CR31","doi-asserted-by":"crossref","unstructured":"Sonzogni M, Hakonen J, Bernab\u00e9 Kleijn M, et al. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes. Mol Autism.\u00a02019;10:23.","DOI":"10.1186\/s13229-019-0277-1"},{"issue":"2","key":"3154_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/nbdi.2001.0463","volume":"9","author":"K Miura","year":"2002","unstructured":"Miura K, Kishino T, Li E, et al. Neurobehavioral and Electroencephalographic Abnormalities in Ube3aMaternal-Deficient Mice. Neurobiol Dis. 2002;9(2):149\u201359.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3154_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/hmg\/ddm288","volume":"17","author":"SV Dindot","year":"2007","unstructured":"Dindot SV, Antalffy BA, Bhattacharjee MB, et al. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet. 2007;17(1):111\u20138.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3154_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/hmg\/ddy345","volume":"28","author":"MW Lewis","year":"2019","unstructured":"Lewis MW, Vargas-Franco D, Morse DA, et al. A mouse model of Angelman syndrome imprinting defects. Hum Mol Genet. 2019;28(2):220\u20139.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3154_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.02.040","volume":"90","author":"MC Judson","year":"2016","unstructured":"Judson MC, Wallace ML, Sidorov MS, et al. GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility. Neuron. 2016;90(1):56\u201369.","journal-title":"Neuron"},{"issue":"1","key":"3154_CR36","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1038\/s41598-017-08825-x","volume":"7","author":"HA Born","year":"2017","unstructured":"Born HA, Dao AT, Levine AT, et al. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice. Sci Rep. 2017;7(1):8451.","journal-title":"Sci Rep"},{"issue":"40","key":"3154_CR37","doi-asserted-by":"publisher","first-page":"13587","DOI":"10.1523\/JNEUROSCI.2194-15.2015","volume":"35","author":"JC Ehlen","year":"2015","unstructured":"Ehlen JC, Jones KA, Pinckney L, et al. Maternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact. J Neurosci. 2015;35(40):13587\u201398.","journal-title":"J Neurosci"},{"issue":"1","key":"3154_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng0197-70","volume":"15","author":"T Kishino","year":"1997","unstructured":"Kishino T, Lalande M, J W. UBE3A\/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15(1):70\u20133.","journal-title":"Nat Genet."},{"issue":"3\u20135","key":"3154_CR39","first-page":"100","volume":"2","author":"A Dagli","year":"2012","unstructured":"Dagli A, Buiting K, Williams CA. Molecular and Clinical Aspects of Angelman Syndrome. Mol Syndromol. 2012;2(3\u20135):100\u201312.","journal-title":"Mol Syndromol"},{"issue":"2","key":"3154_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/geno.1997.4617","volume":"41","author":"YHJ Yamamoto","year":"1997","unstructured":"Yamamoto YHJ, Howley PM. The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics. 1997;41(2):263\u20136.","journal-title":"Genomics"},{"issue":"6509","key":"3154_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/373081a0","volume":"373","author":"M Scheffner","year":"1995","unstructured":"Scheffner M, Nuber U, JM H. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature. 1995;373(6509):81\u20133.","journal-title":"Nature."},{"issue":"2","key":"3154_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s12035-013-8563-y","volume":"49","author":"J El Hokayem","year":"2014","unstructured":"El Hokayem J, Nawaz Z. E6AP in the brain: one protein, dual function, multiple diseases. Mol Neurobiol. 2014;49(2):827\u201339.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"3154_CR43","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1128\/MCB.19.2.1182","volume":"19","author":"Z Nawaz","year":"1999","unstructured":"Nawaz Z, Lonard DM, Smith CL, et al. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol. 1999;19(2):1182\u20139.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"3154_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ng0997-14","volume":"17","author":"CGH Rougeulle","year":"1997","unstructured":"Rougeulle CGH, Lalande M. The Angelman syndrome candidate gene, UBE3A\/E6-AP, is imprinted in brain. Nat Genet. 1997;17(1):14\u20135.","journal-title":"Nat Genet"},{"issue":"8","key":"3154_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/hmg\/ddg106","volume":"12","author":"K Yamasaki","year":"2003","unstructured":"Yamasaki K, Joh K, Ohta T, et al. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet. 2003;12(8):837\u201347.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"3154_CR46","doi-asserted-by":"publisher","first-page":"e522","DOI":"10.1002\/cpz1.522","volume":"2","author":"K Eom","year":"2022","unstructured":"Eom K, Lee HR. Measuring Pattern Separation in Hippocampus by in Situ Hybridization. Curr Protoc. 2022;2(8):e522.","journal-title":"Curr Protoc"},{"issue":"6","key":"3154_CR47","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7","volume":"8","author":"M-B Moser","year":"1998","unstructured":"Moser M-B, Moser EI. Functional differentiation in the hippocampus. Hippocampus. 1998;8(6):608\u201319.","journal-title":"Hippocampus"},{"key":"3154_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nlm.2015.08.001","volume":"124","author":"A Barco","year":"2015","unstructured":"Barco A, Brambilla R, Rosenblum K. Neurobiology of Learning and Memory. Editorial Neurobiol Learn Mem. 2015;124:1\u20132.","journal-title":"Editorial Neurobiol Learn Mem"},{"issue":"11","key":"3154_CR49","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/sleep\/29.11.1380","volume":"29","author":"JA Mindell","year":"2006","unstructured":"Mindell JA, Kuhn B, Lewin DS, et al. Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006;29(11):1380.","journal-title":"Sleep"},{"issue":"10","key":"3154_CR50","first-page":"1277","volume":"29","author":"TI Morgenthaler","year":"2006","unstructured":"Morgenthaler TI, Owens J, Alessi C, et al. Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006;29(10):1277\u201381.","journal-title":"Sleep"},{"issue":"3","key":"3154_CR51","first-page":"21","volume":"5","author":"JA Owens","year":"2006","unstructured":"Owens JA. When child can\u2019t sleep start by treating the parents. Curr Psychiatry. 2006;5(3):21\u201336.","journal-title":"Curr Psychiatry"},{"issue":"1","key":"3154_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejpn.2003.09.006","volume":"8","author":"C Tuffrey","year":"2004","unstructured":"Tuffrey C. A Clinical Guide to Pediatric Sleep. Eur J Paediatr Neurol. 2004;8(1):63.","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"3154_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/00004703-199208000-00009","volume":"13","author":"JA Summers","year":"1992","unstructured":"Summers JA, Lynch PS, Harris JC, et al. A combined behavioral\/pharmacological treatment of sleep-wake schedule disorder in Angelman syndrome. J Dev Behav Pediatr. 1992;13(4):284\u20137.","journal-title":"J Dev Behav Pediatr"},{"key":"3154_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/wps.20674","volume":"18","author":"AD Krystal","year":"2019","unstructured":"Krystal AD, Prather AA, LH A. The assessment and management of insomnia: an update. World Psychiatry. 2019;18:337\u201352.","journal-title":"World Psychiatry."},{"issue":"3","key":"3154_CR55","doi-asserted-by":"publisher","first-page":"e1843","DOI":"10.1002\/mgg3.1843","volume":"10","author":"J Duis","year":"2022","unstructured":"Duis J, Nespeca M, Summers J, et al. A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome. Mol Genet Genomic Med. 2022;10(3):e1843.","journal-title":"Mol Genet Genomic Med"},{"issue":"7","key":"3154_CR56","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s00429-017-1439-6","volume":"222","author":"KY Ng","year":"2017","unstructured":"Ng KY, Leong MK, Liang H, et al. Melatonin receptors: distribution in mammalian brain and their respective putative functions. Brain Struct Funct. 2017;222(7):2921\u201339.","journal-title":"Brain Struct Funct"},{"issue":"6","key":"3154_CR57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/0883073808314153","volume":"23","author":"W Braam","year":"2008","unstructured":"Braam W, Didden R, Smits MG, et al. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial. J Child Neurol. 2008;23(6):649\u201354.","journal-title":"J Child Neurol"},{"issue":"1","key":"3154_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1515\/JPEM.1999.12.1.57","volume":"12","author":"IV Zhdanova","year":"1999","unstructured":"Zhdanova IV, Wurtman RJ, J W. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab. 1999;12(1):57\u201367.","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"9","key":"3154_CR59","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1469-8749.2011.03980.x","volume":"53","author":"DA Rossignol","year":"2011","unstructured":"Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53(9):783\u201392.","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"3154_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.smrv.2008.08.001","volume":"13","author":"AD Krystal","year":"2009","unstructured":"Krystal AD. A compendium of placebo-controlled trials of the risks\/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice. Sleep Med Rev. 2009;13(4):265\u201374.","journal-title":"Sleep Med Rev."},{"issue":"4","key":"3154_CR61","doi-asserted-by":"publisher","first-page":"591","DOI":"10.5664\/jcsm.8284","volume":"16","author":"E Hanzlik","year":"2020","unstructured":"Hanzlik E, Klinger SA, Carson R, et al. Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases. J Clin Sleep Med. 2020;16(4):591\u20135.","journal-title":"J Clin Sleep Med"},{"issue":"7","key":"3154_CR62","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/17512433.2022.2109463","volume":"15","author":"M Ascoli","year":"2022","unstructured":"Ascoli M, Elia M, Gasparini S, et al. Therapeutic approach to neurological manifestations of Angelman syndrome. Expert Rev Clin Pharmacol. 2022;15(7):843\u201350.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"7","key":"3154_CR63","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/BF00304832","volume":"1991","author":"S Ottaviano","year":"1991","unstructured":"Ottaviano S, Giannotti E, Cortesi E. The effect of niaprazine on some common sleep disorders in children. Child\u2019s Nerv Syst. 1991;1991(7):332\u20135.","journal-title":"Child's Nerv Syst."},{"issue":"14","key":"3154_CR64","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1177\/0883073820941755","volume":"35","author":"CS Ryan","year":"2020","unstructured":"Ryan CS, Edlund W, Mandrekar J, et al. Iron Deficiency and Its Role in Sleep Disruption in Patients With Angelman Syndrome. J Child Neurol. 2020;35(14):963\u20139.","journal-title":"J Child Neurol"},{"key":"3154_CR65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nlm.2019.01.011","volume":"160","author":"I Barone","year":"2019","unstructured":"Barone I, Hawks-Mayer H, Lipton JO. Mechanisms of sleep and circadian ontogeny through the lens of neurodevelopmental disorders. Neurobiol Learn Mem. 2019;160:160\u201372.","journal-title":"Neurobiol Learn Mem"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03154-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T11:08:32Z","timestamp":1712315312000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03154-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3154"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03154-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}